NCT00001646View on ClinicalTrials.gov

Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 1997

Study Completion Date

August 31, 2000

Conditions
Acquired Immunodeficiency SyndromeAspergillosisHIV InfectionsImmunologic Deficiency SyndromesNeutropenia
Interventions
DRUG

Voriconazole

DRUG

Amphotericin B

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001646 - Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis | Biotech Hunter | Biotech Hunter